Why Quest Diagnostics Stock Jumped Today
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-10-20 22:41:20

Shares of Quest Diagnostics (DGX 6.32%) climbed 6.3% on Thursday after the medical testing giant boosted its full-year sales and profit forecast.  So what 
Quest's revenue decreased by 10% year over year to $2.5 billion in the third quarter. The decline was driven by a 55% drop in the company's COVID-19 testing sales.
However, Quest's base business revenue, which excludes COVID testing, grew by 5%.
"We accelerated growth in the base business in the third quarter, with a strong performance across much of the country," incoming CEO Jim Davis said.
